Back to search
Short Bowel Syndrome (SBS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Short Bowel Syndrome (SBS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Short Bowel Syndrome (SBS) trials you may qualify forThis is a randomized, double-blind, placebo-controlled, proof-of-concept (PoC), Phase 2 study to assess the safety, PK, and PD of SC administration of HM15912(s…
Eligible patients were randomized into two groups: the GLP-1 group and the control group. The control group received a placebo along with standard care, without…
The purpose of the present Phase 3 trial is to confirm the efficacy and safety of glepaglutide 10 mg twice weekly in a patient population with SBS-IF and genera…
Short Bowel Syndrome (SBS) is a rare condition that happens when a large part of the bowel (also called intestine) is missing or has been removed because of ill…
The objectives of this study are to evaluate the efficacy and safety of crofelemer treatment in adults affected by Short Bowel Syndrome (SBS) with an ileostomy…
Patients with short bowel syndrome have an impact on their quality of life because they need temporary or permanent parenteral nutritional support. The quality…
During the first years following intestinal resection, spontaneous physiological adaptations occur in patients with short bowel syndrome (SBS), allowing improve…
This trial is an extension trial to EASE SBS 2. The study looks at whether glepaglutide is a safe treatment for participants with Short Bowel Syndrome (SBS), as…